General Information
As of 05/25/2012
|
| NAV |
$23.61 |
| NAV Daily Change |
$0.05 |
| % Yield |
0 |
| % SEC Yield |
N/A |
| % YTD Return (as of 04/30/2012) |
11.76 |
| Objective* |
Equity - Sector Health |
| Peer* |
HL MG |
* Key
Portfolio Statistics
|
| % Unrealized Gain YTD |
15.78 |
| Net Assets (Mil $) N/A |
231.02 |
| % Turnover N/A |
130.00 |
Fees
|
| % Max Sales Load |
5.75 |
| % Min Sales Load |
.00 |
| % Max Deferred Load |
.00 |
Expenses
|
| % Max 12b-1 Fee |
.25 |
| % Max Management Fee |
.56 |
| % Redemption Fee |
.75 |
| % Expense Ratio |
1.20 |
Allocation
|
| Large Growth |
17.76 |
| Large Value |
.00 |
| Small Growth |
28.24 |
| Small Value |
.00 |
| Foreign Stock |
.00 |
| Emerging Market |
.00 |
| Precious Metals |
.00 |
| Intermediate Bond |
.00 |
| Foreign Bond |
32.24 |
| High Yield Bond |
.00 |
Portfolio Information |
| Composition |
| As of N/A |
% of Net Assets |
| Stock |
97.20 |
| Cash |
4.30 |
| Bonds |
.00 |
| Preferred |
.00 |
| Convertibles |
.12 |
| Foreign Stock |
15.14 |
| Foreign Bonds |
.00 |
| Hedge |
.00 |
| Other |
-1.63 |
Sector / Country Weightings
|
| As of 01/31/2012 |
% of Portfolio |
| Health |
48.07 |
| Finance |
14.07 |
| Retail Trade |
12.37 |
| Services |
10.45 |
| Other |
7.67 |
| Industrial Cyclical |
5.68 |
| Technology |
1.48 |
| Non-Durable |
.21 |
| N/A |
N/A |
Portfolio Holdings |
Top Equity Holdings
(As of 01/31/2012) |
% of Portfolio |
Value (Mil$) |
|
| AMGEN INC |
6.70 |
31.47 |
| COVIDIEN PLC |
4.42 |
20.78 |
| UNITEDHEALTH GROUP INC |
4.12 |
19.38 |
| GILEAD SCIENCES INC |
4.10 |
19.25 |
| MERCK + CO. INC. |
3.93 |
18.44 |
| WELLPOINT INC |
3.61 |
16.97 |
| EXPRESS SCRIPTS INC |
3.42 |
16.05 |
| MEDCO HEALTH SOLUTIONS INC |
3.34 |
15.70 |
| GLAXOSMITHKLINE PLC ADR |
2.82 |
13.26 |
| N/A |
N/A |
N/A |
|
|
This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Funds over the next 6 months.
| Zacks Rank |
Definition |
| #1 |
Strong Buy |
| #2 |
Buy |
| #3 |
Hold |
| #4 |
Sell |
| #5 |
Strong Sell |
| S&P |
500 |
Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
Zacks Premium Research
|
Zacks Mutual Fund Rank
|
| |
Find similar funds that have a Mutual Fund Rank.
Find Similar Funds Now  |
Fund Description
|
The fund was incepted in September 1996 and is managed by the Fidelity Group. The fund's main objective is to seek capital appreciation. The fund normally invests in common stocks. The fund invests at least 80% of assets in securities of companies principally engaged in the design, manufacture, or sale of products or services used for or in connection with health care or medicine. The management may invest in securities of foreign and domestic issuers. Dividends and capital gains, if any, are distributed annually in December.
|
Stock Holding Statistics
% of Net Assets
|
| As Of |
N/A |
| Total Issues |
96 |
| Avg. P/E |
26.58 |
| Avg. P/Book |
4.53 |
| Avg. EPS Growth |
15.89 |
| Avg. Market Value (Mil $) |
30,395 |
Risk
|
|
3 Year |
5 Year |
10 Year |
| Beta |
0.80 |
0.82 |
0.74 |
| Alpha |
6.34 |
3.98 |
2.12 |
| R Squared |
0.78 |
0.77 |
0.69 |
| Std. Dev. |
14.10 |
17.81 |
14.24 |
| Sharpe |
1.66 |
0.25 |
3.00 |
Shareholder Information
|
| Manager |
Edward Yoon |
| Since |
10/08 |
| Manager Rating * SEE EXPLANTION |
4 |
| Inception Date |
09/03/1996 |
| Shareholders |
15,395 |
| Dividends Paid |
A |
| Minimum Initial Investment |
$2,500 |
| Minimum Subsequent Investment |
$0 |
| IRA Minimum |
$500 |
| IRA Available |
Y |
Check Writing |
N |
Phone Invest |
Y |
| Phone Exchange |
Y |
Phone Redeem |
Y |
Auto Invest |
Y |
| Wire Redeem |
Y |
Wire Fee |
Y |
Wire Transfer |
Y |
Contact Information
|
| Family |
Fidelity |
| Address |
82 Devonshire St
Boston, MA 02109 |
| Phone |
800 544-6666 |
|
Sponsored Links 
